{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:40:22Z","timestamp":1788514822771,"version":"build-2803163510"},"reference-count":97,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2,1]]},"abstract":"<jats:sec>\n                  <jats:title>BACKGROUND AND OBJECTIVES:<\/jats:title>\n                  <jats:p>Echocardiogram is the gold standard for the diagnosis of hemodynamically significant patent ductus arteriosus (hsPDA) in preterm neonates. A simple blood assay for brain natriuretic peptide (BNP) or amino-terminal pro-B-type natriuretic peptide (NT-proBNP) may be useful in the diagnosis and management of hsPDA. Our objectives were to determine the diagnostic accuracy of BNP and NT-proBNP for hsPDA in preterm neonates and to explore heterogeneity by analyzing subgroups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS:<\/jats:title>\n                  <jats:p>The systematic review was performed as recommended by the Cochrane Diagnostic Test Accuracy Working Group. Electronic databases, conference abstracts, and cross-references were searched. We included studies that evaluated BNP or NT-proBNP (index test) in preterm neonates with suspected hsPDA (participants) in comparison with echocardiogram (reference standard). A bivariate random effects model was used for meta-analysis, and summary receiver operating characteristic curves were generated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS:<\/jats:title>\n                  <jats:p>Ten BNP and 11 NT-proBNP studies were included. Studies varied by methodological quality, type of commercial assay, thresholds, age at testing, gestational age, and whether the assay was used to initiate medical or surgical therapy. Sensitivity and specificity for BNP at summary point were 88% and 92%, respectively, and for NT-proBNP they were 90% and 84%, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS:<\/jats:title>\n                  <jats:p>The studies evaluating the diagnostic accuracy of BNP and NT-proBNP for hsPDA varied widely by assay characteristics (assay kit and threshold) and patient characteristics (gestational and chronological age); therefore, generalizability between centers is not possible. We recommend that BNP or NT-proBNP assays be locally validated for specific patient population and outcomes, to initiate therapy or follow response to therapy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.2014-1995","type":"journal-article","created":{"date-parts":[[2015,1,20]],"date-time":"2015-01-20T03:52:49Z","timestamp":1421725969000},"page":"e510-e525","source":"Crossref","is-referenced-by-count":66,"title":["Diagnosing Significant PDA Using Natriuretic Peptides in Preterm Neonates: A Systematic Review"],"prefix":"10.1542","volume":"135","author":[{"given":"Madhulika","family":"Kulkarni","sequence":"first","affiliation":[{"name":"Section of Neonatology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganga","family":"Gokulakrishnan","sequence":"additional","affiliation":[{"name":"Section of Neonatology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Price","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Pediatrics, Texas Children\u2019s Hospital & Baylor College of Medicine, Houston, Texas; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caraciolo J.","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Section of Neonatology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariska","family":"Leeflang","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan","family":"Pammi","sequence":"additional","affiliation":[{"name":"Section of Neonatology and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2015,2,1]]},"reference":[{"issue":"5","key":"2021120906370818200_B1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJM199807303390507","article-title":"Natriuretic peptides.","volume":"339","author":"Levin","year":"1998","journal-title":"N Engl J Med"},{"issue":"1","key":"2021120906370818200_B2","first-page":"91","article-title":"Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man.","volume":"76","author":"Holmes","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2021120906370818200_B3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejheart.2004.01.004","article-title":"Brain and other natriuretic peptides: molecular aspects.","volume":"6","author":"Vanderheyden","year":"2004","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"2021120906370818200_B4","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1373\/clinchem.2006.075713","article-title":"Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review.","volume":"53","author":"Clerico","year":"2007","journal-title":"Clin Chem"},{"issue":"4","key":"2021120906370818200_B5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00246-003-0578-0","article-title":"Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress.","volume":"25","author":"Koulouri","year":"2004","journal-title":"Pediatr Cardiol"},{"issue":"12","key":"2021120906370818200_B6","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.cjca.2013.08.008","article-title":"Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines.","volume":"29","author":"Kantor","year":"2013","journal-title":"Can J Cardiol"},{"issue":"4","key":"2021120906370818200_B7","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1542\/peds.112.4.896","article-title":"Plasma concentrations of aminoterminal pro atrial natriuretic peptide and aminoterminal pro brain natriuretic peptide in healthy neonates: marked and rapid increase after birth.","volume":"112","author":"Mir","year":"2003","journal-title":"Pediatrics"},{"issue":"6","key":"2021120906370818200_B8","doi-asserted-by":"crossref","DOI":"10.1542\/peds.110.6.e76","article-title":"Plasma concentrations of N-terminal pro\u2013brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure.","volume":"110","author":"Mir","year":"2002","journal-title":"Pediatrics"},{"issue":"1","key":"2021120906370818200_B9","doi-asserted-by":"crossref","first-page":"f74","DOI":"10.1136\/adc.2009.158683","article-title":"Cord blood, perinatal BNP values in term and preterm newborns","volume":"95","author":"Mannarino","year":"2010","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"2","key":"2021120906370818200_B10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/jp.2008.185","article-title":"N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants.","volume":"29","author":"Nuntnarumit","year":"2009","journal-title":"J Perinatol"},{"issue":"7","key":"2021120906370818200_B11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/08035250500466647","article-title":"Decreasing ratio of plasma N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide according to age.","volume":"95","author":"Koch","year":"2006","journal-title":"Acta Paediatrica"},{"issue":"10","key":"2021120906370818200_B12","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.2337\/db12-0763","article-title":"Cardiac natriuretic peptides: contributors to cardiac cachexia or possible anti-obesity agents or both?","volume":"61","author":"Costello-Boerrigter","year":"2012","journal-title":"Diabetes"},{"issue":"1\u20132","key":"2021120906370818200_B13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cca.2005.11.005","article-title":"Pediatric brain natriuretic peptide and N-terminal pro\u2013brain natriuretic peptide reference intervals.","volume":"366","author":"Soldin","year":"2006","journal-title":"Clin Chim Acta"},{"issue":"5","key":"2021120906370818200_B14","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1253\/circj.CJ-09-0535","article-title":"The role of N-terminal pro-B-type natriuretic peptide in the diagnosis of congestive heart failure in children. Correlation with the heart failure score and comparison with B-type natriuretic peptide.","volume":"74","author":"Sugimoto","year":"2010","journal-title":"Circ J"},{"issue":"1\u20132","key":"2021120906370818200_B15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cccn.2003.08.016","article-title":"Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay.","volume":"338","author":"Yeo","year":"2003","journal-title":"Clin Chim Acta"},{"issue":"6","key":"2021120906370818200_B16","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.clinbiochem.2006.01.021","article-title":"Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with\/without left ventricular systolic dysfunction.","volume":"39","author":"Vanderheyden","year":"2006","journal-title":"Clin Biochem"},{"issue":"16-17","key":"2021120906370818200_B17","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.clinbiochem.2010.08.002","article-title":"Diagnostic performance of BNP and NT-ProBNP measurements in children with heart failure based on congenital heart defects and cardiomyopathies.","volume":"43","author":"\u015eahin","year":"2010","journal-title":"Clin Biochem"},{"issue":"2","key":"2021120906370818200_B18","first-page":"131","article-title":"Point-of-care testing for B-type natriuretic peptide in premature neonates with patent ductus arteriosus.","volume":"41","author":"Kalra","year":"2011","journal-title":"Ann Clin Lab Sci"},{"issue":"3","key":"2021120906370818200_B19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4070\/kcj.2012.42.3.192","article-title":"B-type natriuretic peptide assay for the diagnosis and prognosis of patent ductus arteriosus in preterm infants.","volume":"42","author":"Kim","year":"2012","journal-title":"Korean Circ J"},{"issue":"2","key":"2021120906370818200_B20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000343034","article-title":"Can early B-type natriuretic peptide assays predict symptomatic patent ductus arteriosus in extremely low birth weight infants?","volume":"103","author":"Lee","year":"2013","journal-title":"Neonatology"},{"issue":"8","key":"2021120906370818200_B21","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1111\/apa.12273","article-title":"B-type natriuretic peptide for assessment of haemodynamically significant patent ductus arteriosus in premature infants.","volume":"102","author":"Mine","year":"2013","journal-title":"Acta Paediatr"},{"issue":"12","key":"2021120906370818200_B22","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/jp.2010.47","article-title":"How useful are B-type natriuretic peptide measurements for monitoring changes in patent ductus arteriosus shunt magnitude?","volume":"30","author":"Chen","year":"2010","journal-title":"J Perinatol"},{"issue":"1","key":"2021120906370818200_B23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jpeds.2009.12.045","article-title":"B-type natriuretic peptide predicts responses to indomethacin in premature neonates with patent ductus arteriosus.","volume":"157","author":"Hsu","year":"2010","journal-title":"J Pediatr"},{"issue":"3","key":"2021120906370818200_B24","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1203\/PDR.0b013e3181799594","article-title":"B-type natriuretic peptide to predict ductus intervention in infants &lt;28 weeks.","volume":"64","author":"Czernik","year":"2008","journal-title":"Pediatr Res"},{"issue":"11","key":"2021120906370818200_B25","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.jp.7211383","article-title":"Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates.","volume":"25","author":"Sanjeev","year":"2005","journal-title":"J Perinatol"},{"issue":"3","key":"2021120906370818200_B26","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2004-1837","article-title":"Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants.","volume":"115","author":"Choi","year":"2005","journal-title":"Pediatrics"},{"issue":"5","key":"2021120906370818200_B27","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1111\/j.1651-2227.2011.02469.x","article-title":"Can a clinical decision rule help ductus arteriosus management in preterm neonates?","volume":"101","author":"Cambonie","year":"2012","journal-title":"Acta Paediatr"},{"issue":"7","key":"2021120906370818200_B28","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00246-011-0020-y","article-title":"Early NT-proBNP is able to predict spontaneous closure of patent ductus arteriosus in preterm neonates, but not the need of its treatment.","volume":"32","author":"Martinovici","year":"2011","journal-title":"Pediatr Cardiol"},{"issue":"4","key":"2021120906370818200_B29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s13312-011-0062-5","article-title":"Patent ductus arteriosus in preterm infants.","volume":"48","author":"Sasi","year":"2011","journal-title":"Indian Pediatr"},{"issue":"8","key":"2021120906370818200_B30","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1651-2227.2009.01315.x","article-title":"Early N-terminal pro\u2013brain natriuretic peptide measurements predict clinically significant ductus arteriosus in preterm infants.","volume":"98","author":"Ramakrishnan","year":"2009","journal-title":"Acta Paediatr"},{"issue":"5","key":"2021120906370818200_B31","doi-asserted-by":"crossref","first-page":"f421","DOI":"10.1136\/adc.2007.119701","article-title":"N-terminal pro-B-type natriuretic peptide as a marker of ductal haemodynamic significance in preterm infants: a prospective observational study.","volume":"92","author":"El-Khuffash","year":"2007","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"4","key":"2021120906370818200_B32","doi-asserted-by":"crossref","first-page":"f320","DOI":"10.1136\/adc.2006.106039","article-title":"Are B-type natriuretic peptide (BNP) and N-terminal-pro-BNP useful in neonates?","volume":"92","author":"El-Khuffash","year":"2007","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"6","key":"2021120906370818200_B33","doi-asserted-by":"crossref","first-page":"f407","DOI":"10.1136\/adc.2007.133140","article-title":"Biochemical markers may identify preterm infants with a patent ductus arteriosus at high risk of death or severe intraventricular haemorrhage.","volume":"93","author":"El-Khuffash","year":"2008","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2021120906370818200_B34","first-page":"175216","article-title":"The use of N-terminal-pro-BNP in preterm infants","volume-title":"Int J Pediatr","author":"El-Khuffash","year":"2009"},{"key":"2021120906370818200_B35","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-2431-14-68","article-title":"B-type natriuretic peptide and mortality in extremely low birth weight infants with pulmonary hypertension: a retrospective cohort analysis","volume":"14","author":"Cuna","year":"2014","journal-title":"BMC Pediatrics"},{"issue":"9","key":"2021120906370818200_B36","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1651-2227.2011.02304.x","article-title":"N-terminal-pro\u2013brain natriuretic peptide: a guide for early targeted indomethacin therapy for patent ductus arteriosus in preterm Infants.","volume":"100","author":"Nuntnarumit","year":"2011","journal-title":"Acta Paediatr"},{"issue":"4","key":"2021120906370818200_B37","doi-asserted-by":"crossref","first-page":"f257","DOI":"10.1136\/adc.2007.120691","article-title":"N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus.","volume":"93","author":"Farombi-Oghuvbu","year":"2008","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"2","key":"2021120906370818200_B38","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000330411","article-title":"Plasma C-terminal pro-endothelin-1 and the natriuretic pro-peptides NT-proBNP and MR-proANP in very preterm infants with patent ductus arteriosus.","volume":"101","author":"Letzner","year":"2012","journal-title":"Neonatology"},{"issue":"4","key":"2021120906370818200_B39","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000334826","article-title":"Urinary NT-proBNP, NGAL, and H-FABP may predict hemodynamic relevance of patent ductus arteriosus in very low birth weight infants.","volume":"101","author":"Tosse","year":"2012","journal-title":"Neonatology"},{"issue":"3","key":"2021120906370818200_B40","first-page":"67","article-title":"Aminoterminal B-type natriuretic peptide (NT-proBNP) in the therapy of patent ductus arteriosus.","volume":"62","author":"Bagnoli","year":"2010","journal-title":"Minerva Pediatr"},{"issue":"2","key":"2021120906370818200_B41","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.semperi.2011.09.023","article-title":"Managing the patent ductus arteriosus in the premature neonate: a new look at what we thought we knew.","volume":"36","author":"Hammerman","year":"2012","journal-title":"Semin Perinatol"},{"issue":"1","key":"2021120906370818200_B42","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00246-009-9568-1","article-title":"N-terminal-pro-B-type natriuretic peptide in premature patent ductus arteriosus: a physiologic biomarker, but is it a clinical tool?","volume":"31","author":"Hammerman","year":"2010","journal-title":"Pediatr Cardiol"},{"issue":"1","key":"2021120906370818200_B43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.earlhumdev.2008.05.008","article-title":"Correlation between cord blood, perinatal BNP values and echocardiographic parameters in healthy Italian newborns.","volume":"85","author":"Mannarino","year":"2009","journal-title":"Early Hum Dev"},{"issue":"5","key":"2021120906370818200_B44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.earlhumdev.2010.04.003","article-title":"BNP concentrations and cardiovascular adaptation in preterm and fullterm newborn infants.","volume":"86","author":"Mannarino","year":"2010","journal-title":"Early Hum Dev"},{"issue":"3","key":"2021120906370818200_B45","doi-asserted-by":"crossref","first-page":"f178","DOI":"10.1136\/adc.2008.147587","article-title":"B-type natriuretic peptide concentrations to guide treatment of patent ductus arteriosus.","volume":"94","author":"Attridge","year":"2009","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"6","key":"2021120906370818200_B46","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1542\/peds.2005-1387","article-title":"Longitudinal changes of brain-type natriuretic peptide in preterm neonates.","volume":"117","author":"da Graca","year":"2006","journal-title":"Pediatrics"},{"issue":"1","key":"2021120906370818200_B47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1042\/CS20020046","article-title":"Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus arteriosus in preterm infants.","volume":"103","author":"Puddy","year":"2002","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"2021120906370818200_B48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jpeds.2005.03.040","article-title":"The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates.","volume":"147","author":"Flynn","year":"2005","journal-title":"J Pediatr"},{"issue":"2","key":"2021120906370818200_B49","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1651-2227.2001.tb00282.x","article-title":"Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants.","volume":"90","author":"Holmstr\u00f6m","year":"2001","journal-title":"Acta Paediatr"},{"issue":"1","key":"2021120906370818200_B50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1042\/CS20020114","article-title":"Natriuretic peptides as markers of patent ductus arteriosus in preterm infants.","volume":"103","author":"Holmstrom","year":"2002","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"2021120906370818200_B51","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/jp.2012.86","article-title":"Urinary NT-proBNP and ductal closure in preterm infants.","volume":"33","author":"Czernik","year":"2013","journal-title":"J Perinatol"},{"issue":"5","key":"2021120906370818200_B52","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0022-3476(95)70172-9","article-title":"Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation.","volume":"127","author":"Kluckow","year":"1995","journal-title":"J Pediatr"},{"issue":"4","key":"2021120906370818200_B53","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/01.CIR.50.4.821","article-title":"Echocardiographic assessment of ductus arteriosus shunt in premature infants.","volume":"50","author":"Silverman","year":"1974","journal-title":"Circulation"},{"issue":"2","key":"2021120906370818200_B54","doi-asserted-by":"crossref","first-page":"f112","DOI":"10.1136\/fn.70.2.F112","article-title":"Re-evaluation of the left atrial to aortic root ratio as a marker of patent ductus arteriosus.","volume":"70","author":"Iyer","year":"1994","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"8","key":"2021120906370818200_B55","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"2021120906370818200_B56"},{"key":"2021120906370818200_B57","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/pr.2011.868","article-title":"Does serum brain natriuretic peptide (BNP) together with a novel PDA score improve PDA treatment selection?","volume":"70","author":"Elsayed","year":"2011","journal-title":"Pediatr Res"},{"key":"2021120906370818200_B58","unstructured":"Elsayed YN, Dakshinamurti S, Soni R, Baier J, Buffo I, Seshia M. Does bedside measurement of serum brain natriuretic peptide (BNP) at 48 to 72 hours of age improve PDA treatment selection? Pediatric Academic Societies Annual Meeting PAS2012:16756. 2012. Available at: http:\/\/www.abstracts2viewcom\/pas\/"},{"key":"2021120906370818200_B59","unstructured":"Deorari AKSA, Saxena A, Mani K, Vivekanandan S, Agarwal R, Paul VK. N-terminal pro\u2013brain natriuretic peptide (NTpBNP) in diagnosis of hemodynamically significant patent ductus arteriosus (hs-PDA) in preterm VLBW infants. Pediatric Academic Societies Annual Meeting E-PAS20111453597. 2011. Available at: http:\/\/www.abstracts2viewcom\/pas\/"},{"issue":"2","key":"2021120906370818200_B60","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4103\/2249-4847.96758","article-title":"NT-proBNP levels improve the ability of predicting a hemodynamically significant patent ductus arteriosus in very low-birth weight infants","volume":"1","author":"Buddhe","year":"2012","journal-title":"J Clin Neonatol"},{"key":"2021120906370818200_B61","doi-asserted-by":"crossref","DOI":"10.1038\/pr.2011.892","article-title":"Serial N-Terminal Pro-Brain Natriuretic Peptide Measurement as a Predictor of Clinically Significant Ductus Arteriosus in Preterm Infants beyond the First Week of Life.","author":"Letshwiti","year":"2011"},{"issue":"5","key":"2021120906370818200_B62","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1651-2227.2004.tb02984.x","article-title":"N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases.","volume":"93","author":"Nir","year":"2004","journal-title":"Acta Paediatrica"},{"issue":"6","key":"2021120906370818200_B63","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00392-005-0246-x","article-title":"Reference values of NT-proBNP serum concentrations in the umbilical cord blood and in healthy neonates and children.","volume":"94","author":"Schwachtgen","year":"2005","journal-title":"Z Kardiol"},{"issue":"3","key":"2021120906370818200_B64","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1651-2227.2011.02468.x","article-title":"The definition of a haemodynamic significant duct in randomized controlled trials: a systematic literature review.","volume":"101","author":"Zonnenberg","year":"2012","journal-title":"Acta Paediatr"},{"key":"2021120906370818200_B65","doi-asserted-by":"crossref","first-page":"a228","DOI":"10.1136\/archdischild-2012-302724.0794","article-title":"PDA score at 48 to 72 hours of age (Manitoba score) predicts a hemodynamically significant PDA.","volume":"97","author":"Elsayed","year":"2012","journal-title":"Arch Dis Child"},{"issue":"3","key":"2021120906370818200_B66","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1203\/00006450-199003000-00011","article-title":"Changes in vasopressin, atrial natriuretic factor, and water homeostasis in the early stage of bronchopulmonary dysplasia.","volume":"27","author":"Kojima","year":"1990","journal-title":"Pediatr Res"},{"issue":"9","key":"2021120906370818200_B67","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2459\/JCM.0b013e32832c15fb","article-title":"Diagnostic accuracy and clinical relevance of brain natriuretic peptide assay in pediatric patients with congenital heart diseases.","volume":"10","author":"Cantinotti","year":"2009","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"5","key":"2021120906370818200_B68","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/CIRCHEARTFAILURE.109.849299","article-title":"Prognostic value of biomarkers in heart failure: application of novel methods in the community.","volume":"2","author":"Dunlay","year":"2009","journal-title":"Circ Heart Fail"},{"issue":"2","key":"2021120906370818200_B69","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/03009734.2012.751471","article-title":"Ruling out cardiac failure: cost\u2013benefit analysis of a sequential testing strategy with NT-proBNP before echocardiography.","volume":"118","author":"Ferrandis","year":"2013","journal-title":"Ups J Med Sci"},{"issue":"1","key":"2021120906370818200_B70","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1017\/S0266462312000712","article-title":"Cost\u2013utility analysis of nt-probnp-guided multidisciplinary care in chronic heart failure.","volume":"29","author":"Moertl","year":"2013","journal-title":"Int J Technol Assess Health Care"},{"issue":"6","key":"2021120906370818200_B71","first-page":"881","article-title":"Estimation of the possible economic effects of a sequential testing strategy with NT-proBNP before echocardiography in primary care.","volume":"60","author":"Khezri","year":"2014","journal-title":"Clin Lab"},{"key":"2021120906370818200_B72","unstructured":"Reitsma JB, Rutjes AWS, Whiting P, Vlassov VV, Leeflang MMG, Deeks JJ. Assessing methodological quality. In: Deeks JJ, Bossuyt PM, Gatsonis C, eds. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 100. Oxford, England: The Cochrane Collaboration; 2009. Available at: http:\/\/srdta.cochrane.org\/"},{"issue":"12","key":"2021120906370818200_B73","doi-asserted-by":"crossref","first-page":"889","DOI":"10.7326\/0003-4819-149-12-200812160-00008","article-title":"Systematic reviews of diagnostic test accuracy.","volume":"149","author":"Leeflang","year":"2008","journal-title":"Ann Intern Med"},{"issue":"17","key":"2021120906370818200_B74","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3109\/14767058.2014.880879","article-title":"Correlation analysis between echocardiographic flow pattern and N-terminal-pro\u2013brain natriuretic peptide for early targeted treatment of patent ductus arteriosus","volume":"27","author":"Occhipinti","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2021120906370818200_B75","unstructured":"Elsayed Y, Seshia MM, Buffo I, Soni NR, Baier RJ, Dakshinamurti S. Serial measurement of serum brain-type natriuretic peptide (BNP) predicts need for surgical PDA ligation. Pediatric Academic Societies Annual Meeting E-PAS2013:2923401. 2013. Available at: http:\/\/www.abstracts2view.com\/pas\/"},{"key":"2021120906370818200_B76","unstructured":"Elsayed Y, Baier RJ, Seshia MM, Dakshinamurti S. Does serum brain-type natriuretic peptide (BNP) identify compromised regional blood flow in infants with PDA? Pediatric Academic Societies Meeting 2013 E-PAS2013:1532413. 2013. Available at: http:\/\/www.abstracts2view.com\/pas\/"},{"key":"2021120906370818200_B77","unstructured":"Hollinger SM, Shah DS, Hothi J, et al. Beyond the bench: evaluating the clinical utility of B-type natriuretic peptide in the diagnosis of patent ductus arteriosus in preterm neonates. Pediatric Academic Societies Annual Meeting E-PAS2011:514. 2011. Available at: http:\/\/www.abstracts2view.com\/pas\/"},{"key":"2021120906370818200_B78","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/pr.2011.882","article-title":"Evaluation of near-patient B-type natriuretic peptide assay in predicting patent ductus arteriosus closure in preterm infants (\u226427+6 weeks) with low dose indomethacin prophylaxis regime.","volume":"70","author":"Jeevananthan","year":"2011","journal-title":"Pediatr Res"},{"key":"2021120906370818200_B79","first-page":"92","article-title":"The relation between brain natriuretic peptide and patent ductus arteriosus in premature infants.","volume":"47","author":"Kazanci","year":"2012","journal-title":"Turk Arch Ped"},{"key":"2021120906370818200_B80","unstructured":"Perugu S, Rehan V, Chow S. Baylen B. Serial echocardiograms and a multibiomarker approach for the assessment of ventricular function in very low birth weight infants. Pediatric Academic Societies Meeting 2011 E-PAS2011:3832319. 2011. Available at: http:\/\/www.abstracts2view.com\/pas\/"},{"key":"2021120906370818200_B81","unstructured":"Tauber K, Doyle R, Cummings JJ, Clements KE, Granina E, Munshi UK. Early BNP levels predict PDA in preterm neonates. Pediatric Academic Societies Annual Meeting E-PAS2013:43405. 2013. Available at: http:\/\/www.abstracts2view.com\/pas\/"},{"key":"2021120906370818200_B82","article-title":"Elevated urinary NT-proBNP after pharmacological closure of patent ductus arteriosus in very low birth weight infants.","author":"Celik","year":"2012;89(3):187\u2013189","journal-title":"Early Hum Dev"},{"issue":"2","key":"2021120906370818200_B83","doi-asserted-by":"crossref","first-page":"f133","DOI":"10.1136\/adc.2010.185967","article-title":"Troponin T, N-terminal pro natriuretic peptide and a patent ductus arteriosus scoring system predict death before discharge or neurodevelopmental outcome at 2 years in preterm infants.","volume":"96","author":"El-Khuffash","year":"2011","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2021120906370818200_B84","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/pr.2011.501","article-title":"Increased plasma N-terminal pro-BNP in neonates less than 32 weeks gestation with open ductus arteriosus.","volume":"70","author":"Sellmer","year":"2011","journal-title":"Pediatr Res"},{"key":"2021120906370818200_B85","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1203\/00006450-201011001-00217","article-title":"N-terminal pro\u2013brain natriuretic peptide levels and its relation with the patent ductus arteriosus in premature neonates.","volume":"68","author":"Yildirim","year":"2010","journal-title":"Pediatr Res"},{"issue":"5","key":"2021120906370818200_B86","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1515\/CCLM.2010.129","article-title":"Reference intervals for brain natriuretic peptide in healthy newborns and infants measured with an automated immunoassay platform.","volume":"48","author":"Cantinotti","year":"2010","journal-title":"Clin Chem Lab Med"},{"issue":"15","key":"2021120906370818200_B87","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.jacc.2009.06.020","article-title":"Accuracy of plasma B-type natriuretic peptide to diagnose significant cardiovascular disease in children: the Better Not Pout Children! Study.","volume":"54","author":"Law","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"2021120906370818200_B88","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/heart.89.8.875","article-title":"Normal values of B type natriuretic peptide in infants, children, and adolescents.","volume":"89","author":"Koch","year":"2003","journal-title":"Heart"},{"issue":"4","key":"2021120906370818200_B89","first-page":"191","article-title":"Plasma brain natriuretic peptide and the evaluation of volume overload in infants and children with congenital heart disease.","volume":"57","author":"Kunii","year":"2003","journal-title":"Acta Med Okayama"},{"issue":"2","key":"2021120906370818200_B90","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1530\/eje.0.1330207","article-title":"Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth","volume":"133","author":"Yoshibayashi","year":"1995","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2021120906370818200_B91","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00246-008-9258-4","article-title":"NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies.","volume":"30","author":"Nir","year":"2009","journal-title":"Pediatr Cardiol"},{"issue":"1","key":"2021120906370818200_B92","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1515\/CCLM.2006.016","article-title":"N-terminal pro\u2013brain natriuretic peptide: normal ranges in the pediatric population including method comparison and interlaboratory variability.","volume":"44","author":"Albers","year":"2006","journal-title":"Clin Chem Lab Med"},{"issue":"9","key":"2021120906370818200_B93","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1373\/49.9.1563","article-title":"Plasma N-terminal pro-B-type natriuretic peptide concentrations in a control population of infants and children.","volume":"49","author":"Rauh","year":"2003","journal-title":"Clin Chem"},{"issue":"6","key":"2021120906370818200_B94","first-page":"429","article-title":"Values of brain natriuretic peptide and N-terminal pro\u2013brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease","volume":"11","author":"Zhang","year":"2009","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"issue":"5","key":"2021120906370818200_B95","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1373\/clinchem.2005.048892","article-title":"N-terminal pro-B-type natriuretic peptide concentrations in mothers just before delivery, in cord blood, and in newborns.","volume":"51","author":"Bar-Oz","year":"2005","journal-title":"Clin Chem"},{"issue":"5","key":"2021120906370818200_B96","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1373\/clinchem.2004.046557","article-title":"N-terminal pro-B-type natriuretic peptide concentrations are markedly higher in the umbilical cord blood of newborns than in their mothers.","volume":"51","author":"Hammerer-Lercher","year":"2005","journal-title":"Clin Chem"},{"issue":"12","key":"2021120906370818200_B97","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1373\/clinchem.2004.040253","article-title":"Reference values for N-terminal pro-B-type natriuretic peptide in umbilical cord blood.","volume":"50","author":"Bakker","year":"2004","journal-title":"Clin Chem"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/135\/2\/e510\/1058187\/peds_2014-1995.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/135\/2\/e510\/1058187\/peds_2014-1995.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:57:39Z","timestamp":1639097859000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/135\/2\/e510\/33420\/Diagnosing-Significant-PDA-Using-Natriuretic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,1]]},"references-count":97,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,2,1]]},"published-print":{"date-parts":[[2015,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2014-1995","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,1]]}}}